New Company Abyrx, Inc. Acquires Substantially All of the Assets of ORTHOCON and DRG; Fully-Capitalizes to Accelerate Growth of Exciting New Biosurgical Product Portfolio
4/25/2013 10:27:58 AM
More...
|
ORTHOCON Announces Uninterrupted Availability of HEMASORB Resorbable Hemostatic Bone Putty
8/24/2012 10:43:46 AM
More...
|
ORTHOCON Names David J. Hart Vice President of Business Operations
3/15/2012 10:30:06 AM
More...
|
ORTHOCON Announces Signing of Exclusive Worldwide License Agreement With Bezwada Biomedical
8/31/2011 6:35:48 AM
More...
|
ORTHOCON Receives 510(k) Clearance to Market HEMASORB Apply
6/1/2011 7:10:18 AM
More...
|
ORTHOCON Receives CE Mark and Health Canada Medical Device License for HEMASORB(R)
4/21/2011 6:52:20 AM
More...
|
ORTHOCON Announces U.S. Market Launch of HEMASORB(R)
2/17/2011 7:23:41 AM
More...
|
ORTHOCON Names John J. Pacifico President and Chief Executive Officer
1/10/2011 6:31:54 AM
More...
|
ORTHOCON Announces Appointment of New CEO and $25 Million Series B Financing
4/8/2009 7:13:02 AM
More...
|